-
-
-
-
-
-
-
Pre-Open Stock Movers 08/23: (TRIL) (XERS) (AXSM) Higher; (LYFT) (UBER) (BGS) Lower (more...)
-
-
-
-
-
-
-
Dynavax (DVAX) Says FDA Requested More Info on HEPLISAV-B
-
-
-
-
-
-
-
Dynavax Reports First Quarter 2017 Financial Results
-
-
-
-
-
-
-
Dynavax (DVAX) Says FDA to Review its Complete Response to November CRL and PDUFA Action Date for HEPLISAV-B
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/07: (LPCN) (UVE) (GPS) Higher; (CLVS) (MG) (OPK) Lower (more...)
-
-
-
-
-
-
-
Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B
-
-
-
-
-
-
-
Dynavax (DVAX) Annoucnes HBV-23 Met co-Primary Endpoints
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

